Latest News - Danaher
Top Corporates Hub
Danaher
Masimo Buyout By Danaher Faces Shareholder Scrutiny On Deal Value
11.04.2026 09:12
Danaher has agreed to acquire Masimo (NasdaqGS:MASI) in an all cash deal, subject to approval by Masimo shareholders. Several shareholder law firms have announced legal investigations into whether the deal terms and sales process are fair to Masimo investors. The outcome of the shareholder vote and any legal actions could affect the timing, terms, or completion of the transaction. Masimo shares most recently closed at $178.32, with the stock up 40.0% year to date and 15.9% over the past...
Assessing Danaher (DHR) Valuation After Recent Share Price Weakness And Undervalued Fair Value Estimate
09.04.2026 14:12
Danaher at a glance: business mix and recent stock performance Danaher (DHR) has a market value of about US$135.2b and last closed at US$196.19. Recent returns show a 2.7% move over the past day, with a 2.8% gain over the past week. Over the past month the stock shows a 1.3% decline, while the past 3 months reflect a 16.5% decline. Year to date, Danaher’s total return is a 14.8% decline, with a 1 year total return of 2.9%. On a longer view, Danaher’s 3 year total return stands at a 10.0%...
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
08.04.2026 09:01
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and over the past six months, the industry has held its ground with a flat return while the S&P 500 fell by 2.1%.
Evercore ISI Cuts Danaher (DHR) Price Target, Adds Shares to Tactical Outperform List
08.04.2026 04:14
Danaher Corporation (NYSE:DHR) is included among the 15 Best Low Volatility Blue Chip Stocks to Buy Now. On April 6, Evercore ISI analyst Vijay Kumar lowered the firm’s price recommendation on Danaher Corporation (NYSE:DHR) to $225 from $254 and maintained an Outperform rating. The shares were also added to the firm’s “Tactical Outperform” list as part […]
What to Expect From Danaher Corporation's Q1 2026 Earnings Report
06.04.2026 12:10
Danaher Corporation is approaching its first-quarter earnings release in a few weeks, and Wall Street is forecasting a low single-digit percentage rise in earnings.
Danaher: A Great Way To Play Healthcare For Long-Term Dividend Growth Investors
06.04.2026 09:30
Danaher has increased its dividend for 13 consecutive years, and its dividend growth has been nothing short of spectacular. See why I rate DHR stock a buy.
3 Reasons to Avoid DHR and 1 Stock to Buy Instead
02.04.2026 19:36
Although the S&P 500 is down 2.8% over the past six months, Danaher’s stock price has fallen further to $190.75, losing shareholders 9.3% of their capital. This might have investors contemplating their next move.
Danaher Insiders Sell US$483m Of Stock, Possibly Signalling Caution
01.04.2026 13:00
In the last year, many Danaher Corporation ( NYSE:DHR ) insiders sold a substantial stake in the company which may have...
3 Cash-Producing Stocks We Keep Off Our Radar
26.03.2026 11:12
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Has Danaher (DHR) Weak Share Price Opened A Valuation Opportunity?
26.03.2026 05:04
If you are wondering whether Danaher at around US$187 per share now reflects good value or lingering caution, you are not alone. The stock has recently seen a 2.3% decline over the last week, an 11.3% decline over the last month, and is down 18.8% year to date and 10.5% over the past year, which may change how you think about its risk and return trade off. These price moves sit against a backdrop where Danaher continues to attract investor attention as a large life sciences and diagnostics...
Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference
24.03.2026 14:43
Danaher Corporation (NYSE:DHR) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 3, 2026, Danaher Corporation (NYSE:DHR) presented its 2026 strategic vision at the TD Cowen 46th Annual Health Care Conference. CEO Rainer Blair projected revenue growth of 3%-6% for 2026, driven by the bioprocessing segment. Also, […]
Spotting Winners: Danaher (NYSE:DHR) And Research Tools & Consumables Stocks In Q4
24.03.2026 12:02
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Danaher (NYSE:DHR) and its peers.
IDBS Award Highlights Danaher’s Growing Biopharma Software And Recurring Revenue Story
14.03.2026 09:09
IDBS, a Danaher company, received the Best Biologics Digitalisation: Software Innovation Award at the 2026 Asia Pacific Biopharma Excellence Awards. The recognition highlights IDBS’s role in biopharma digitalisation across the Asia Pacific region. The award draws attention to Danaher’s growing cloud software presence within its broader life sciences portfolio. For investors watching NYSE:DHR, this award puts a spotlight on a part of Danaher’s business that sits away from traditional...
Jim Cramer on Agilent Technologies: “I Don’t Think You Need It”
11.03.2026 11:28
Agilent Technologies, Inc. (NYSE:A) is one of the stocks on which Jim Cramer expressed his thoughts. A caller asked if the stock will ever come back, and here’s what Cramer had to say in response: You know, they do so much test and measurement that is biotech. It’s almost like a Danaher, which stopped working. […]
Beckman Coulter Diagnostics Selects Innovaccer Gravity™ as AI and Data Platform for Clinical Laboratory Operations Modernization
09.03.2026 13:00
SAN FRANCISCO, March 09, 2026--Innovaccer Inc., a leading healthcare AI company, today announced that Beckman Coulter Diagnostics, a global clinical diagnostics leader and a Danaher company, has selected Gravity, Innovaccer’s enterprise data and AI platform, to support its vision for modernizing and scaling customers’ clinical laboratory operations.
Pall Corporation Appoints Dr. Roland Folz as President
03.03.2026 13:00
Pall Corporation, a Danaher company and a global leader in filtration, separation and purification, announced the appointment of Dr. Roland Folz as President, Pall Corporation, effective March 3, 2026.
1 Profitable Stock to Target This Week and 2 We Avoid
03.03.2026 10:22
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness
28.02.2026 02:13
If you are wondering whether Danaher is priced fairly today, or if the current share price leaves some value on the table, this article is for you. The stock last closed at US$209.94, with returns of 0.2% over 7 days, a 6.5% decline over 30 days, an 8.9% decline year to date, and a 1.7% gain over 1 year, set against a 5 year return of 10.9% and a 3 year return of a 5.0% decline. Recent interest in Danaher has been shaped by ongoing coverage of its position in the pharmaceuticals and biotech...
Where is Danaher Corporation (DHR) Headed?
27.02.2026 04:53
Danaher Corporation (NYSE:DHR) is one of the best strong buy healthcare stocks to invest in. Danaher Corporation (NYSE:DHR) announced on February 24 that its Board of Directors approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026, to holders of record on March 27, 2026. In […]